Survey Finds Two-Thirds of Leading Pharmas Restrict ChatGPT Usage, While Many in Life Sciences Industry Deem AI ‘Overrated’

  In the ongoing debate over the integration of artificial intelligence (AI) into various industries, the biopharmaceutical sector is taking a cautious approach. According to a recent survey conducted by ZoomRx among over 200 professionals in life sciences, more than…